ネオアンチゲンターゲット治療の世界市場レポート 2023年以下を含む:1) タイプ別2)免疫療法タイプ別:DNAまたはRNAベースワクチン; タンパク質ベースワクチン; 樹状細胞ワクチン; TILベース療法3) 対象疾患別適応症別:対象疾患別: 大腸がん; 腎細胞がん; 非小細胞肺がん; 骨がん; 婦人科がん4) 投与経路別:皮内;静脈内;皮下5) 用途別医療研究機関;病院;クリニックCovering:F. Hoffmann-La Roche AG; Merck and Co.Inc.、Bristol Myers Squibb Company、GlaxoSmithKline plc、Eli Lilly and CompanyNeoantigen Targeted Therapies Global Market Report 2023Including: 1) By Type: Monotherapy; Combination Therapy2) By Immunotherapy Type: DNA Or RNA-Based Vaccines; Protein-Based Vaccines; Dendritic Cell Vaccines; TIL-Based Therapies3) By Target Disease Indication: Colorectal Cancer; Renal Cell Carcinoma; Non-Small Cell Lung Cancer; Bone Cancer; Gynecological Cancer4) By Route of Administration: Intradermal; Intravenous; Subcutaneous5) By Application: Medical Research Institution; Hospital; and ClinicCovering: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; GlaxoSmithKline plc; Eli Lilly and Company The Business Research Companyのネオアンチゲンターゲット療法の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 当レポートは、力... もっと見る
サマリーThe Business Research Companyのネオアンチゲンターゲット療法の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。当レポートは、力強い成長を遂げている新抗原標的療法市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 ネオアンチゲン標的療法の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社のネオアンチゲン標的療法世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。 当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、動向、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) タイプ別単剤療法;併用療法 2) 免疫療法のタイプ別DNAまたはRNAベースワクチン;タンパク質ベースワクチン;樹状細胞ワクチン;TILベース療法 3) 標的疾患別適応症大腸がん;腎細胞がん;非小細胞肺がん;骨がん;婦人科がん 4) 投与経路別皮内投与、静脈内投与、皮下投与 5) 用途別医療研究機関、病院、クリニック、その他の用途 言及された企業F. ホフマン・ラ・ロシュ社、Merck and Co.Inc.、Bristol Myers Squibb Company、GlaxoSmithKline plc、Eli Lilly and Company 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Neoantigen Targeted Therapies Market Characteristics 3. Neoantigen Targeted Therapies Market Trends And Strategies 4. Neoantigen Targeted Therapies Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Neoantigen Targeted Therapies Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Neoantigen Targeted Therapies Market Segmentation 6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Monotherapy Combination Therapy 6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion DNA Or RNA-Based Vaccines Protein-Based Vaccines Dendritic Cell Vaccines TIL-Based Therapies 6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Colorectal Cancer Renal Cell Carcinoma Non-Small Cell Lung Cancer Bone Cancer Gynecological Cancer 6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Intradermal Intravenous Subcutaneous 6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Medical Research Institution Hospital And Clinic Other Applications 7. Neoantigen Targeted Therapies Market Regional And Country Analysis 7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Neoantigen Targeted Therapies Market 8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Neoantigen Targeted Therapies Market 9.1. China Neoantigen Targeted Therapies Market Overview 9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Neoantigen Targeted Therapies Market 10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Neoantigen Targeted Therapies Market 11.1. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Neoantigen Targeted Therapies Market 12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Neoantigen Targeted Therapies Market 13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Neoantigen Targeted Therapies Market 14.1. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Neoantigen Targeted Therapies Market 15.1. Western Europe Neoantigen Targeted Therapies Market Overview 15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Neoantigen Targeted Therapies Market 16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Neoantigen Targeted Therapies Market 17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Neoantigen Targeted Therapies Market 18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Neoantigen Targeted Therapies Market 19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Neoantigen Targeted Therapies Market 20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Neoantigen Targeted Therapies Market 21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview 21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Neoantigen Targeted Therapies Market 22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Neoantigen Targeted Therapies Market 23.1. North America Neoantigen Targeted Therapies Market Overview 23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Neoantigen Targeted Therapies Market 24.1. USA Neoantigen Targeted Therapies Market Overview 24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Neoantigen Targeted Therapies Market 25.1. Canada Neoantigen Targeted Therapies Market Overview 25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Neoantigen Targeted Therapies Market 26.1. South America Neoantigen Targeted Therapies Market Overview 26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Neoantigen Targeted Therapies Market 27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Neoantigen Targeted Therapies Market 28.1. Middle East Neoantigen Targeted Therapies Market Overview 28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Neoantigen Targeted Therapies Market 29.1. Africa Neoantigen Targeted Therapies Market Overview 29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles 30.1. Neoantigen Targeted Therapies Market Competitive Landscape 30.2. Neoantigen Targeted Therapies Market Company Profiles 30.2.1. F. Hoffmann-La Roche AG 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Merck and Co. Inc. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Bristol Myers Squibb Company 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. GlaxoSmithKline plc 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Eli Lilly and Company 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies 31.1. Kite Pharma Inc. 31.2. Gilead Sciences Inc. 31.3. Amgen Inc. 31.4. Moderna Inc. 31.5. BioNTech SE 31.6. Bavarian Nordic Inc. 31.7. Advaxis Inc. 31.8. Immatics NV 31.9. Precision Biologics Inc. 31.10. Iovance Biotherapeutics Inc. 31.11. Agenus Inc. 31.12. Achilles Therapeutics Plc 31.13. Medigene AG 31.14. Gritstone Bio Inc. 31.15. SQZ Biotechnologies Company 32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking 33. Global Neoantigen Targeted Therapies Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market 35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis 35.1 Neoantigen Targeted Therapies Market In 2027 - Countries Offering Most New Opportunities 35.2 Neoantigen Targeted Therapies Market In 2027 - Segments Offering Most New Opportunities 35.3 Neoantigen Targeted Therapies Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryNeoantigen Targeted Therapies Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Neoantigen Targeted Therapies Market Characteristics 3. Neoantigen Targeted Therapies Market Trends And Strategies 4. Neoantigen Targeted Therapies Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Neoantigen Targeted Therapies Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Neoantigen Targeted Therapies Market Segmentation 6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Monotherapy Combination Therapy 6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion DNA Or RNA-Based Vaccines Protein-Based Vaccines Dendritic Cell Vaccines TIL-Based Therapies 6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Colorectal Cancer Renal Cell Carcinoma Non-Small Cell Lung Cancer Bone Cancer Gynecological Cancer 6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Intradermal Intravenous Subcutaneous 6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Medical Research Institution Hospital And Clinic Other Applications 7. Neoantigen Targeted Therapies Market Regional And Country Analysis 7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Neoantigen Targeted Therapies Market 8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Neoantigen Targeted Therapies Market 9.1. China Neoantigen Targeted Therapies Market Overview 9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Neoantigen Targeted Therapies Market 10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Neoantigen Targeted Therapies Market 11.1. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Neoantigen Targeted Therapies Market 12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Neoantigen Targeted Therapies Market 13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Neoantigen Targeted Therapies Market 14.1. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Neoantigen Targeted Therapies Market 15.1. Western Europe Neoantigen Targeted Therapies Market Overview 15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Neoantigen Targeted Therapies Market 16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Neoantigen Targeted Therapies Market 17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Neoantigen Targeted Therapies Market 18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Neoantigen Targeted Therapies Market 19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Neoantigen Targeted Therapies Market 20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Neoantigen Targeted Therapies Market 21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview 21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Neoantigen Targeted Therapies Market 22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Neoantigen Targeted Therapies Market 23.1. North America Neoantigen Targeted Therapies Market Overview 23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Neoantigen Targeted Therapies Market 24.1. USA Neoantigen Targeted Therapies Market Overview 24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Neoantigen Targeted Therapies Market 25.1. Canada Neoantigen Targeted Therapies Market Overview 25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Neoantigen Targeted Therapies Market 26.1. South America Neoantigen Targeted Therapies Market Overview 26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Neoantigen Targeted Therapies Market 27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Neoantigen Targeted Therapies Market 28.1. Middle East Neoantigen Targeted Therapies Market Overview 28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Neoantigen Targeted Therapies Market 29.1. Africa Neoantigen Targeted Therapies Market Overview 29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles 30.1. Neoantigen Targeted Therapies Market Competitive Landscape 30.2. Neoantigen Targeted Therapies Market Company Profiles 30.2.1. F. Hoffmann-La Roche AG 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Merck and Co. Inc. 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Bristol Myers Squibb Company 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. GlaxoSmithKline plc 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Eli Lilly and Company 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies 31.1. Kite Pharma Inc. 31.2. Gilead Sciences Inc. 31.3. Amgen Inc. 31.4. Moderna Inc. 31.5. BioNTech SE 31.6. Bavarian Nordic Inc. 31.7. Advaxis Inc. 31.8. Immatics NV 31.9. Precision Biologics Inc. 31.10. Iovance Biotherapeutics Inc. 31.11. Agenus Inc. 31.12. Achilles Therapeutics Plc 31.13. Medigene AG 31.14. Gritstone Bio Inc. 31.15. SQZ Biotechnologies Company 32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking 33. Global Neoantigen Targeted Therapies Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market 35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis 35.1 Neoantigen Targeted Therapies Market In 2027 - Countries Offering Most New Opportunities 35.2 Neoantigen Targeted Therapies Market In 2027 - Segments Offering Most New Opportunities 35.3 Neoantigen Targeted Therapies Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート
本レポートと同じKEY WORD(immunotherapy)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|